Sefydlwyd yr adolygiad ym mis Gorffennaf 2016 gan ganolbwyntio'n benodol ar ystyried y meini prawf sy'n cael eu defnyddio i bennu amgylchiadau clinigol eithriadol ar gyfer IPFR a'r cyfle i leihau nifer y paneli IPFR yng Nghymru. Roedd safbwynt y claf yn rhan amlwg o'r adolygiad.
The review was established in July 2016 with a particular focus on considering the “clinical exceptionality” decision making criteria for IPFR and the scope to reduce the number of IPFR panels in Wales. Central to the review was the patient perspective.